Cervical tsDCS on Stroke Patients
Key facts
- Where
- Roma and Rome, ItalySee the 2 sites
Where in Italy
- IRCCS San Raffaele RomaRoma, ItalyTaking people
- IRCCS San Raffaele RomaRome, ItalyNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- IRCCS San Raffaele Roma
- Trial code
- NCT06826274
- Record updated
- 6 November 2026
- Original description
The present project aims to evaluate the facilitatory modulation of motor responses of the limb upper limb by tsDCS in patients with arm/hand hyposthenia after cerebral ischemia to verify the possible therapeutic benefits that this type of stimulation can induce in terms of of strength, dexterity and effectiveness in acts of daily living.Read full original descriptionShow less
Clinical and Neurophysiological Evaluation of the Effects of Cervical tsDCS on Stroke Patients With Distal Upper Limb Strength Deficit
The present project aims to evaluate the facilitatory modulation of motor responses of the limb upper limb by tsDCS in patients with arm/hand hyposthenia after cerebral ischemia to verify the possible therapeutic benefits that this type of stimulation can induce in terms of of strength, dexterity and effectiveness in acts of daily living.
Inclusion: age over 18 years; first ischemic/hemorrhagic stroke (within 30 days of onset); mild-to-moderate stroke (NIHSS scale score<16); residual function of the upper limb, assessed by the following scales: - MRC of the distal muscles of the upper limb: score between 2 and 4; - NHISS (items 5A and 5B): score between 1 and 3; ability to give informed consent and understand instructions; age over 18 years; equalized in age with the patient group.
Exclusion: history of disabling neurological disease; history of epilepsy; history of stroke progress; history of severe neurological disease; severe spasticity (Ashworth Scale score > 2); severe aphasia; severe neglect; significant comorbidities; contraindications to tsDCS; Healthy Group:.
Group Stroke:.